NIPER Hyderabad lays strong emphasis on the sponsored research, collaborative research funded by the international and national agencies and strong industrial interaction. The institute has set up modern laboratories and the supporting infrastructure. The sponsored research has also emerged as a crucial factor in the creation of the infrastructure while strengthening the facilities in some of the emerging areas of technology.
| S.No. | Name of Faculty (Principal Investigator) | Name of the Funding Agency | Title of the Project | Sanctioned Order No. | Sanctioned Date | Amount received (In Rupees) |
|---|---|---|---|---|---|---|
| 22 | Dr. Neelesh Kumar Mehra (PI) Dr. Dharmendra Khatri (Co-PI) Dr. Vivek Singh (Co-PI) |
Department of science and technology (DST), New Delhi | Development of Novel Eye Drops of fixed dose combination for Effective Ocular Delivery | F. No. DST/NM/NS/2021/405 | 23.06.2021 | Rs. 29,20,000 |
| 21 | Dr. Neelesh Kumar Mehra (PI) Dr. Dharmendra Khatri (Co-PI) Dr. Pankaj K Singh (Co-PI) |
Central Council of Research in Unani Medicine (CCRUM), New Delhi India | Pharmacological activities and pre-clinical screening of the promising unani medicines against hepatic disease | F. No. 3-12/2021-CCRUM/Tech | 23.06.2021 | Rs. 24,53,360 |
| 20 | Dr. Saurabh Srivastava | NBI, Gurugram | Development and evaluation of oral drug delivery systems for colon targeting of drugs for the local & systemic actions | NBI/R&D/SLIDD/011 | 10.04.2021 | 8.26 Lakhs |
| 19 | Dr. Manoj P. Dandekar | Unique Biotech | To study the effect of selective probiotics with glutamine on depression-like phenotype in Sprague-Dawley rats | NA | 20.11.2020 | 1,50,000 |
| 18 | Dr. Manoj P. Dandekar | DST-SERB | Role of age- and sex-specific gut microbiota in brain injury for microbiome-based therapeutics | SRG/2020/002439 | 05.10.2020 | 32,69,512 |
| 17 | Dr. Santosh Kumar Guru | DST-SERB | Analysis of the role of extracellular vesicles (Exosomes) in drug tolerant persister cells and its contribution to cancer initiating cells in breast cancer | SRG/2020/002013 | 17.03.2021 | 21,89,000 |
| 16 | Dr. Dharmendra K. Khatri | NBI Biosciences Pvt. Ltd, Gurgaon, India. | In vitro screening of Dopamine decarboxylase (DDC) inhibition potential and Blood brain barrier (BBB) status of plant-based molecules | NA | 16.11.2020 | 6,17,249 |
| 15 | Dr. Dharmendra K. Khatri | NBI Biosciences Pvt. Ltd, Gurgaon, India. | To study the efficacy of therapeutic plant molecule in animal models to treat Chronic Obstructive Pulmonary Disease (COPD) by the lung regeneration/repair process | File no: NBI/R&D/COPD/03 | 12.05.2021 | 16,67,930 |
| 14 | Dr Saurabh Srivastava and Dr Neelesh Kumar Mehra | DRL, DRDO, Tezpur, India | Development, Evaluation and Characterization of Hydrophobic Nanoparticles Impregnated Fabrics to be Assessed as Dress Material For Defense | File no: DRL/1205/TC | 03-11-2020 | 9.9 Lakhs |
| 13 | Dr Neelesh Kumar Mehra Dr Chandraih Godugu |
CCRUM, New Delhi | Formulation, Development, Evaluation and Assessment of Safety and toxicity of Unani Herbal toothpaste (Sunoon-e-Mustahkam-e-Dandan) | File no: ........ | 07-10-2020 | 04,50,000 |
| 12 | Dr. Y.V. Madhavi | -- | Development of scalable, safe and cost effective process for the API of Umifenovir (Arbidol) a promising repurposed drug for COVID-19 in India | File no: ........ | 22/01/2021 | 10,00,000 |
| 11 | Dr. Ashutosh Kumar | CCRUM, New Delhi | Preclinical Evaluation of UNIM-401 and UNIM-403 for Psoriasis and UNIM-404 and UNIM-405 for vitiligo | File no: ........ | 08/09/2019 | 58,00,000 |
| 10 | Dr. Y.V Madhavi | Life Sceinces Research Board (LSRB), DRDO | Development of a scalable route for the manufacture of Prussian Blue insoluble of pharmaceutical grade, an FDA approved decorporation drug | File no: LSRB-344/SH&DD/2019 | 13/06/2019 | 49,76,640 |
| 9 | Dr. S. Gananadhamu | DST-SERB-EMEQ | Studying the role of reactive impurities in excipients on the formation of degradation products with genotoxic potential | File no: EEQ/2018/001461 | 22/02/2019 | 32,39,000.00 |
| 8 | Dr. Md. Arifuddin & Dr. M. Mallika | DBT | Design and Development of novel antitubercular agents targeting Shikimate Kinase protein | File No: BT/PT23619/MED/29/1199/2017 | 09/01/2018 | Rs. 46,55,000 |
| 7 | Dr Nanduri Srinivas | SERB - Extra Mural Project | Synthesis and therapeutic evaluation of new LpxC inhibitors as potent anti- bacterial agents | File No: EMR/2017/000220 | 12/05/2017 | Rs. 43,00,000 |
| 6 | Dr Chandraiah Godugu | DST-DAAD | Targeting Lysyl Oxidase-2 and miRNA for Effective Gene Therapy of Liver fibrosis | DST/INT/FRG/DAAD/P-01/2017 | 12/07/2017 | Rs. 19,90,000 |
| 5 | Dr. Ashutosh Kumar | DST (EMR project) | Evaluation of neuroprotective effects of AMPK & SIRT1 modulation in experimental diabetic neuropathy using pharmacological approaches | File No: EMR/2016/006258 | 20/04/2017 | Rs. 46,00, 000 |
| 4 | Dr. Ashutosh Kumar | DST (indo-poland) collaboration | Evaluation of Anti-Glycation and Antioxidant Properties of Natural Polyphenolic Compounds in Experimental Models of Diabetic Complications. | File No: DST/INT/Pol/P-30/2016 | 04/01/2017 | Rs. 22,00, 000 |
| 3 | Dr. N. Satheesh Kumar | DST- SERB-EMR | Herb - Drug Interactions: Transport and Metabolism of herbal slimming agents in the presence of lipase inhibitors, antihyperglycemic agents, HMG-CoA reductase inhibitor and hypocholesterolemic agent | File No: EMR/2016/002098 | 24/01/2017 | Rs. 51,57, 585 |
| 2 | Dr. T. D. Neelima | DST | Polycyclic 1,4-Benzoxazines via Oxidative Dearomatization and Intramolecular aza-Michael and aza-Diels-Alder Cyclization. Synthesis Of Levofloxacin | 2017 | Rs. 36,00,000 | |
| 1 | Dr. M. Mallika | DBT, India | Discovery of non-carbohydrate selective inhibitors of the galectin-1 for the treatment of cancer | File No: 6242-19/RGCB/PMD/DBT/MLKA/2015 | 24/05/2017 | Rs.5,69,190.00 |
The NIPER Hyderabad has expertise in various research areas to provide knowledge and intellectual inputs which are of interest to the industry and other organisations.
| S.No. | Name of Faculty (Principal Investigator) | Name of the Funding Agency | Title of the Project | Sanctioned Order No. | Sanctioned Date | Amount received (In Rupees) |
|---|---|---|---|---|---|---|
| 1 | Dr.M.Mallika | M/S ISSAR Pharma Pvt Ltd, Hyderabad | Bioinformatics work | 2017 | Rs. 283500 |
